Overview of NDC 51991-0334
NDC 51991-0334 corresponds to Carbinoxamine Maleate, a medication manufactured and distributed by Breckenridge Pharmaceutical, Inc. This drug is used to treat allergic symptoms such as runny nose, sneezing, and itchy or watery eyes.
Market Context
Pharmaceutical Market Trends
The pharmaceutical market is experiencing several key trends that can impact the pricing and market dynamics of drugs like Carbinoxamine Maleate.
-
Specialty Pharmaceuticals: The market is seeing a significant rise in the cost and utilization of specialty pharmaceuticals, which treat complex or chronic conditions. However, Carbinoxamine Maleate is not classified as a specialty drug but is still subject to broader market trends[4].
-
Biosimilars and Generics: The growth of biosimilars and generic drugs is expected to influence the market. While Carbinoxamine Maleate is a generic drug, its pricing can be affected by the overall dynamics of generic drug pricing. For instance, the median price increase for generic drugs was reported to be 19.9% in some cases, although this can vary widely[2].
Price Transparency and Regulation
Price transparency and regulatory measures are becoming more stringent, which can impact drug pricing.
-
Price Transparency Programs: Programs like the Oregon Drug Price Transparency Program require manufacturers to report price increases and new high-cost drugs. This transparency can help in understanding the factors influencing drug prices, including those for generic medications like Carbinoxamine Maleate[2].
-
Regulatory Oversight: Regulatory bodies are increasing their oversight on pharmaceutical pricing, including monitoring costs to consumers and reporting requirements for various entities in the supply chain. This could lead to more stable or controlled price increases for generic drugs[2].
Price Projections
Current Pricing Environment
The current pricing environment for generic drugs is characterized by variable price increases. Here are some key points to consider:
-
Generic Drug Price Increases: The median price increase for generic drugs has been reported to be around 19.9%, although extreme cases like a 2,527% increase for a generic naproxen have been noted. However, such drastic increases are rare and typically associated with specific market conditions[2].
-
Stable Pricing for Some Generics: Many generic drugs, including those from Breckenridge Pharmaceutical, Inc., tend to have more stable pricing due to market competition and regulatory oversight.
Specific Projections for NDC 51991-0334
Given the stable nature of generic drug pricing and the absence of specific data indicating otherwise, here are some projections:
-
Moderate Price Increases: It is likely that Carbinoxamine Maleate will experience moderate price increases, if any, aligning with the overall trend of generic drug pricing. A projection of a 2-5% annual price increase would be reasonable, considering the broader market trends and regulatory environment[4].
-
Market Competition: The presence of multiple manufacturers for generic drugs like Carbinoxamine Maleate helps maintain competitive pricing. This competition is likely to keep price increases in check.
-
Regulatory Impact: Continued regulatory oversight and transparency programs will help ensure that any price increases are justified and not excessively high.
Key Factors Influencing Pricing
Supply Chain Dynamics
-
Pharmacy Benefit Managers (PBMs): PBMs play a significant role in negotiating prices and managing formularies. Their strategies can influence the pricing of generic drugs like Carbinoxamine Maleate[2].
-
Manufacturer Reporting: Manufacturers are required to report price increases, which helps in monitoring and controlling excessive price hikes[2].
Technological and Data Trends
- Use of AI and Data Analytics: The increasing use of AI and data analytics in the pharmaceutical industry can help in optimizing pricing strategies and predicting market trends. However, this is more relevant to complex and high-cost drugs rather than generic medications like Carbinoxamine Maleate[3].
Conclusion
The pricing of Carbinoxamine Maleate (NDC 51991-0334) is likely to remain relatively stable, with moderate price increases if any, due to the competitive nature of the generic drug market and regulatory oversight. Here are the key takeaways:
Key Takeaways
- Stable Pricing: Generic drugs like Carbinoxamine Maleate tend to have stable pricing due to market competition.
- Moderate Increases: Any price increases are likely to be moderate, in the range of 2-5% annually.
- Regulatory Oversight: Continued regulatory measures will help in monitoring and controlling price increases.
- Supply Chain Dynamics: PBMs and manufacturer reporting requirements play a crucial role in managing drug prices.
FAQs
-
What is the current market trend for generic drug pricing?
- The current trend shows moderate price increases, with a median increase of 19.9% for generic drugs, although this can vary widely.
-
How does regulatory oversight impact drug pricing?
- Regulatory oversight helps in monitoring and controlling price increases through transparency programs and reporting requirements.
-
What role do PBMs play in drug pricing?
- PBMs negotiate prices and manage formularies, influencing the pricing of generic drugs.
-
How might AI and data analytics affect drug pricing?
- AI and data analytics can help in optimizing pricing strategies and predicting market trends, but this is more relevant to complex and high-cost drugs.
-
What is the projected price increase for Carbinoxamine Maleate?
- A moderate price increase of 2-5% annually is projected, considering the stable nature of generic drug pricing and regulatory environment.
Sources
- FDA Report: NDC 51991-934 - FDA.report
- Oregon Drug Price Transparency Program: Prescription Drug Price Transparency Results and Recommendations
- Intelligencia AI Blog: 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch
- Vizient Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
- FindACode: Breckenridge Pharmaceutical, Inc. - List of Drugs - NDC Labeler
